BrainStorm Cell Therapeutics of Petah Tikva is recruiting American patients for a Phase 3 clinical study of its NurOwn stem-cell treatment intended to halt progression of amyotrophic lateral sclerosis (ALS). The announcement was made in a patient webinar last week. The NurOwn platform grew out of a technique developed at Tel Aviv University...

North Carolina Democratic Gov. Roy Cooper signed legislation on Thursday prohibiting the state from doing business with companies that boycott Israel. The bipartisan bill, which passed North Carolina’s House of Representatives by a vote of 96-19 and Senate by a vote of 45-3 last month, also requires the state to divest...

In its criticism of Senate legislation against anti-Israel boycotts, the American Civil Liberties Union (ACLU) has falsely described the bill as an unconstitutional attack on free speech, a legal scholar argued in The Washington Post on Thursday. The ACLU’s claims that Israel Anti-Boycott Act inhibits the free expression of ideas are “as weak as...

Phibro Animal Health and Zydus Cadila recently announced their intention to enter into a long-term deal that would see the Indian company license Israeli Phibro’s innovative poultry vaccine technologies. A Globes report said the five-year deal was worth $150 million. “We are proud of the more than 20-year partnership with Zydus Cadila...

A new venture capital fund focused on Israel’s automotive technology sector said on Wednesday that it raised over $40 million, twice its target. Maniv Mobile LP said it will help investors partner with emerging leaders in transportation technology, The Times of Israel reported. It currently has 15 companies—mostly Israeli startups—in its...

Palestinian Authority President Mahmoud Abbas is refusing demands from the White House to stop incitement over the Temple Mount and call for an end to protests, Haaretz reported Thursday. U.S. officials urged the PA to de-escalate tensions, citing Israeli efforts to defuse the situation in the wake of a July 14 terror attack...